Fundamentals

Silexion Therapeutics Corp

SLXN

Soon

Sentiment

Soon

Options

Revenue

0.00

0.000.00%

-

Assets

3.09M

▲562.00k▲22.26%

3 Months Change

Liabilities

7.67M

▲5.29M▲223.19%

3 Months Change

Free Cash Flow

-2.67M

▼-1.98M▼-286.25%

12 Months Change

Revenue/Cost Of Revenue

Quarterly

Net Profit/Loss

Quarterly

Assets/Liabilities

Quarterly

Cash Flows

Quarterly

Quarterly

Outstanding Shares

Quarterly

Recent Quarterly and Annual Filings

ID: 0001178913-24-003421

ID: 0001178913-24-003180

ID: 0001178913-24-003126

ID: 0001213900-24-080268

ID: 0001213900-24-076715

ID: 0001213900-24-073934

ID: 0001213900-24-071491